Omeprazole Impurity F, also known by its chemical name 2,12-Dihydro-1,3-dimethyl-8-methoxy-12-thioxobenzo[4,5]pyrido[1,2-c]imidazo[1,2-a]imidazol-2-one, is a synthetic organic compound that serves as an impurity in the synthesis of omeprazole, a widely used proton pump inhibitor. This compound features a complex bicyclic structure that includes multiple functional groups, such as methoxy and thioxo moieties, contributing to its chemical reactivity and stability. It is characterized by its molecular weight, specific melting point, and solubility properties, which are essential for its identification and quantification in pharmaceutical formulations. The presence of this impurity is typically monitored during the quality control processes of omeprazole production to ensure compliance with regulatory standards. As with many pharmaceutical impurities, its toxicological profile and potential effects on human health are of interest, necessitating thorough investigation during drug development and safety assessments.

OMEPRAZOLE IMP. F (EP): 2,12-DIHYDRO-1,3-DIMETHYL-8-METHOXY-12-THIOXOBENZO[4,5]PYRIDO[1,2-C]IMIDAZO[1,2-A]IMIDAZOL-2-ONE MM STANDARD

2748245-58-9: Omeprazole Impurity F, also known by its chemical name 2,12-Dihydro-1,3-dimethyl-8-methoxy-12-thioxobenzo[4,5]pyrido[1,2-c]imidazo[1,2-a]imidazol-2-one, is a synthetic organic compound that serves as an impurity in the synthesis of omeprazole, a widely used proton pump inhibitor. This compound features a complex bicyclic structure that includes multiple functional groups, such as methoxy and thioxo moieties, contributing to its chemical reactivity and stability. It is characterized by its molecular weight, specific melting point, and solubility properties, which are essential for its identification and quantification in pharmaceutical formulations. The presence of this impurity is typically monitored during the quality control processes of omeprazole production to ensure compliance with regulatory standards. As with many pharmaceutical impurities, its toxicological profile and potential effects on human health are of interest, necessitating thorough investigation during drug development and safety assessments.

CAS 2748245-58-9

OMEPRAZOLE IMP. F (EP): 2,12-DIHYDRO-1,3-DIMETHYL-8-METHOXY-12-THIOXOBENZO[4,5]PYRIDO[1,2-C]IMIDAZO[1,2-A]IMIDAZOL-2-ONE MM STANDARD

Esomeprazole Impurity 20

Ref: ST-EA-CP-E14035